The benefits of statins for both primary and secondary prevention of coronary heart disease (CHD) are limited mainly to patients under 80. We examined the impact of the new General Medical Services (GMS) contract on measurement of lipids and prescribing of statins in patients over 80 years of age with CHD. We found that there has been a significant increase in both, with little evidence supporting this and substantial financial implications. National guidance on the assessment and management of lipids in the over 80s in the new GMS contract is urgently required.
The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease
November 2006Br J Cardiol 2006;13:367-9 Leave a commentClick any image to enlarge
